COMMUNIQUÉS West-GlobeNewswire

DLH to Provide Mission-Critical Cyber Support for U.S. Navy
18/08/2026
ATLANTA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026
Interim financial results, 9M 2025/26 1 October 2025 - 30 June 2026 Coloplast delivered Q3 organic growth of 6% and 5% EBIT growth 1 in constant currencies. Strong quarter in both Chronic Care ex. China and [...]
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
18/08/2026
Research evaluating the influence of placental tissue processing on wound-healing biology accepted for presentation at leading wound care scientific meeting SCOTTSDALE, Ariz., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Applied [...]
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
18/08/2026
Event highlights a significant expansion in small-molecule API commercial capacity and a new kilo-scale GMP facility dedicated to HPAPIs and ADC payloads RANCHO CORDOVA, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- SK [...]
U.S. Oral Surgery Management Partners with Cottonwood Oral & Maxillofacial Surgery of Albuquerque
18/08/2026
IRVING, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has secured a partnership [...]
Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026
Physiotherapist Laith Cunneen on Channel 7’s Sunrise. Supplied by Arcane Physio Peak Physio has opened Arcane Physio, a clinical education and reference platform, to external subscribers, targeting physiotherapists [...]
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026
Enrollment in the SUPRAME Phase 3 trial of anzu-cel (anzutresgene autoleucel, IMA203) remains on track to complete the required randomizations by year-end to support final analysis for the primary PFS endpoint; [...]
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company [...]
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18/08/2026
Total revenue increases by 14% to CHF 119 million Operating profit increases by 32% to CHF 32 million and net profit by 77% to CHF 28 million Fosmanogepix phase 3 program on track for data readout and regulatory [...]
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026
Interim financial results, 9M 2025/26 1 October 2025 - 30 June 2026 Coloplast delivered Q3 organic growth of 6% and 5% EBIT growth 1 in constant currencies. Strong quarter in both Chronic Care ex. China and [...]
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18/08/2026
Dr. Charuworn’s extensive immunology drug development experience will help accelerate the clinical development of Coultreon’s first-in-class SIK3 inhibitor COL-5671 Leuven, Belgium. August 18, 2026 . Coultreon Biopharma [...]
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
18/08/2026
Research by the UK in-home veterinary provider found 67% of pet owners had no idea a vet could come to the house to put pets to sleep. Chichester, West Sussex, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cloud 9 Vets, a national [...]
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
18/08/2026
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical [...]
Transactions in connection with share buy-back program
18/08/2026
Company announcement no. 31 - 26 18 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
18/08/2026
BEIJING, Aug. 18, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
Functional Brands Announces Second Quarter 2026 Financial Results
17/08/2026
LAKE OSWEGO, Ore., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Functional Brands Inc. (OTC Markets: MEHA), a leading innovator in wellness and performance products, today announced financial results for the second quarter ended [...]
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an investigational, [...]
La Fenice Centre Brings Independently Published Frequency Therapy Research to Thornbury
17/08/2026
Co-founder Deanna Pietramala's Brain Science study adds outside validation to the clinic's therapies Thornbury, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Deanna Pietramala, co-founder of La Fenice Centre for Neuro Integrative [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
BRISBANE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]

Pages